The manufacturing plant for the product of ‘Botulinum Toxin’, PROTOX Research Institute
Management and manufacturing the safety product via a bio plant with the advanced production facilities.
Construction of the bio plant
The bio plant of PROTOX capable of producing and managing ‘Botulinum Toxin’ preparations with a surface area of about 6,280㎡ within the Pharmaceutical Complex of Hyangnam was designed and built in accordance with global GMP guidelines.